Cargando…
Amino acid management of Parkinson’s disease: a case study
An extensive list of side effects and problems are associated with the administration of l-dopa (l-3, 4-dihydroxyphenylalanine) during treatment of Parkinson’s disease. These problems can preclude achieving an optimal response with l-dopa treatment. PURPOSE: To present a case study outlining a novel...
Autores principales: | Hinz, Marty, Stein, Alvin, Uncini, Thomas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068871/ https://www.ncbi.nlm.nih.gov/pubmed/21475622 http://dx.doi.org/10.2147/IJGM.S16621 |
Ejemplares similares
-
Amino acid-responsive Crohn’s disease: a case study
por: Stein, Alvin, et al.
Publicado: (2010) -
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
por: Hinz, Marty, et al.
Publicado: (2011) -
A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
por: Hinz, Marty, et al.
Publicado: (2010) -
APRESS: apical regulatory super system, serotonin, and dopamine interaction
por: Hinz, Marty, et al.
Publicado: (2011) -
Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”
por: Hinz, Marty, et al.
Publicado: (2011)